| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |